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ABSTRACT
The Hha\ methyltransferase recognizes the sequence
GCGC and transfers a methyl group to C5 of the first
cytoslne residue. All m5C-methyltransferases contain
a highly conserved sequence motif called the P-C motif.
The cystelne residue of this motif Is Involved In
catalysis by forming a covalent bond with the 6-position
of cytoslne prior to methyl group transfer. For the
EcoRII methyltransferase, It has been shown that
substitution of this catalytic cystelne by glyclne is
cytotoxlc to E.coll cells expressing the mutant
methyltransferase (Wyszynskl et al. Nucl. Acids Res.
20: 319,1992). We now show that this observation can
be extended to the Hha\ system and suggest that the
cytotoxlclty is due to abnormally tight DNA binding by
the mutant methyltransferase, which probably
interferes with replication or transcription.
INTRODUCTION
5-methylcytosine methyltransferases (m3C-methyltransferases)
are present in organisms ranging from bacteria to mammals (1).
These enzymes transfer a methyl group from S-adenosyl-
methionine (SAM) to the C5 position of a cytosine residue in
a specific double-stranded DNA sequence. The family of m5C-
methyltransferases shares an overall common architecture: there
are five highly conserved motifs about 10 to 20 amino acids long
and five moderately conserved motifs (2). Motif I, located near
the N-terminus, has a close relative in many other families of
protein, DNA and RNA methyltransferases, and may be
important for SAM interaction (3,4). Recognition of a specific
DNA sequence by the methyltransferases is mediated by a
'variable region' that lies between conserved motifs VHI and IX
(5,6). Motif IV, called the P-C motif, is part of the catalytic center
of the enzyme. It has been proposed by Santi (7) that cytosine
methyltransferases use a mechanism analogous to that employed
by thymidylate synthase (8) in which an early reaction step
involves formation of a transient covalent protein-DNA
intermediate between a Cys residue in the enzyme and the C6
position of cytosine (7,9). The methyl group, donated by SAM,
is transferred to the C5 position. Several studies have shown that
cytosine methyltransferases interact with DNA containing
5-azacytidine (5-azaQ or 5-fluorocytosine, both potent inhibitors
of m5C-methyltransferases, to form a covalent complex with the
enzyme (10,11). Amino acid Cys-71, located in the P-C motif
of the HaeHl methyltransferase, has been identified recently as
the active catalytic site (10).
It was first observed for the SPR multi-specific
methyltransferase that replacement of the cysteine residue in the
P-C motif by serine destroyed catalytic activity (12). A later,
more extensive study of the EcdRE methyltransferase (M.£coRTJ,
recognition sequence CCWGG), showed that replacement of the
conserved cysteine with serine, valine or tryptophan abolished
catalysis (13). A glycine substitution both abolished catalysis and
proved cytotoxic to E. coli (13). In this paper we show that Hhal
methyltransferase (M.Hhal, recognition sequence GCGC)
exhibits similar properties when the conserved Cys-81 in the P-
C motif is altered. Mutants in which Cys-81 was replaced with
Arg, His or Ser only lost methyltransferase activity. In contrast,
the Gly-81 mutant lost activity and was cytotoxic. A biochemical
basis for this cytotoxicity was sought. Here, we demonstrate that
the Gly-81 substitution lowered the K^ of the enzyme for its
DNA substrate about 3-fold and its k ^ about 50-fold. This
enhanced affinity for target DNA probably interferes with cellular
DNA replication or transcription causing cytoxicity.
MATERIALS AND METHODS
Bacterial strains and plasmids
Escherichia coli K-12 strains: ER1727 [A(mcrB-mrr)102::-Tnl0,
mcrA1272::TnlO, F' lac proAB lacFAQacZ)M15] was kindly
provided by E. Raleigh. Plasmid pHSH0-l, which encodes the
HO methyltransferase (5), contains a mutant form (I2L) of
M.Hhal under the control of the T7 promoter. The properties
of this mutant are indistinguishable from wild-type (5). Plasmid
pATT contains M . & J I and was kindly provided by W.Jack (New
England Biolabs). Plasmid pGEM-3Zf(+), containing the fl
origin, used for preparation of single stranded DNA for site
directed mutagenesis, was purchased from Promega.
Enzymes and reagents
Restriction enzymes, T4 DNA ligase, Vent DNA polymerase
and bacteriophage lambda phage DNA were from New England
Biolabs and used according to the manufacturer's specifications.
Deoxycytidine-5'[a-32P]-triphosphate and deoxyadenosine-
* To whom correspondence should be addressed at: New England Biolabs, 32 Tozer Road, Beverly, MA 01915, USA
Downloaded from https://academic.oup.com/nar/article-abstract/21/10/2459/1259029
by Cold Spring Harbor Laboratory user
on 08 November 2017
2460 Nucleic Acids Research, 1993, Vol. 21, No. 10
(6000 Ci/mmole) were from Amersham.
DNA sequencing was performed using a kit from United States
Biochemicals and site-directed mutagenesis was performed using
a kit from Amersham. S-adenosyl-L[methyl-3H]methionine
(15 CiAnmol) was from Amersham.
Site-directed mutagenesis
The following primers were synthesized by the Midland certified
reagent company for use in mutagenesis.
A: TGTGCAGGGTTTCCGCAC.CAAGCGTTT
B: GCAGGGTTTCCGVGCCAAGCGTTT
The underlined codon CAC in primer A encodes a histidine.
Oligonucleotide B is degenerate at the position marked V (A/G/Q
to generate codons encoding either serine (AGC), glycine (GGQ,
or arginine (CGC). Plasmid pGEM3Zf(+)flfaI was constructed
by subcloning the Sphl-Hindm fragment containing the whole
reading frame of the M.Hhal gene from plasmid pHSHO-1 into
pGEM3Zf(+). PlasmidspGEM3Zf(+)M.#/wI-His81, -Ser81,
-Gly81 and -Arg81 contain mutations of Cys81 made by
oligonucleotide directed mutagenesis (14) using oligonucleotides
A or B. Mutations were confirmed by dideoxy chain termination
sequencing. Plasmid pUHE25 is an expression vector carrying
the T7 early promoter/lac operator sequence (15) and was a gift
of U. Deuschle. Plasmids pUHE25Gly-81, pUHE25Arg-81,
pUHE25Ser-81 and pUHE25His-81 were constructed by ligating
the Sphl-Hindm fragment from pGEM3Zf(+)M.fl7wI-Gly-81,
Ser-81, Arg-81 and His-81, respectively, into identical sites
within plasmid pUHE25.
Purification of M.Hhal and mutants
The Arg-81, Ser-81 and His-81 mutants of M.Hhal were purified
as described by Kumar et al. (16) except that no SAM was added.
The following method was used to purify the Gly-81 mutant.
Plasmid pUHE25Gly-81 and plasmid pAIT2, expressing M.Sssl,
were cotransformed into ER1727 cells and selected using
ampicillin and kanamycin. Cells were grown to an ODgoo of
0.4, then induced by adding IPTG to a final concentration of 400
/xg/ml. The cells were harvested after induction for 2 hrs. The
cell pellet was resuspended in 10 mM HEPES (pH 7.2), 50 mM
NaCl, 5 mM Na2EDTA, 0.1% 2-mercaptoethanol and 10%
glycerol. The crude cell extract was prepared using a French press
(1200 psi) and precipitated by 20% (NH^SO,,. The pellet was
resuspended in 20 mM Tris.HCl (pH 8.0), 50 mM NaCl, 5 mM
Na2EDTA, 0.1% b-mercaptoethanol and 10% glycerol. The
protein was dialyzed against the same buffer to remove
(NH^SCv Dialyzed material was applied to a Pharmacia
MONO-Q FPLC column (HR5/5, Anion exchanger) using a flow
rate of 0.5 ml/min. The protein was eluted at approximately 110
mM NaCl using a 20 ml linear gradient of NaCl (100-400 mM).
In each case the final preparations were 90—95% pure as judged
by SDS-polyacrylamide gel electrophoresis and Coomassie blue
staining.
Assays for methylation activity
a. Sensitivity to restriction endonucleases. Plasmid DNAs,
carrying wild-type or mutant methyltransferases were isolated
using the alkaline lysis method (17), further purified on Qiagen
columns and then digested with an excess of the Hhal restriction
endonuclease (R.Hhal). Typically 0.3 ng plasmid DNA was
digested with 20 units R.Hhal for 2 hrs at 37 CC. The digestion
products were analyzed by 1 % agarose gel electrophoresis in the
presence of ethidium bromide.
b. In vitro methylation activity. Bacteriophage lambda DNA,
digested with R.HindUl was incubated in the presence of [3H-
methyl]-SAM with various purified methyltransferase proteins.
Briefly the reaction was performed in 20 fd methylation buffer
containing 50 mM Tris.HCl (pH 7.5), 10 mM Na2EDTA, 5
mM b-mercaptoethanol, 65 /iM [3H]-SAM typically using 54
nM methyltransferase and 1 ng DNA. Samples were incubated
at 37°C for 60 mins. The incubation mixture was then treated
with proteinase K at 65°C for 20 mins. and analyzed by a DE81
filter binding assay (18).
Mobility shift assays
The following oligonucleotides for use in gel retardation assays
were synthesized at New England Biolabs or in the Cold Spring
Harbor Oligonucleotide facility.
1. 5'- GAC TGG TAC ACT ATC AGG CGC TGA CCC ACA ACA TCC G -3'
2.5'- GAC TGG TAC ACT ATC AGG "CGC TGA CCC ACA ACA TCC G -3'
3. 5'- TCG GAT GTT GTG GGT CAG CGC CTG ATA CTG TAC CAG T -3'
4. 5'- TCG GAT GTT CTG GGT CAG -"CGC CTG ATA CTG TAC CAG T -3'
5. 5'- TGC AGT CGC GAT GCC GGG TCA CCT TGA GG -3'
6. 5'- GTC AGC GCT ACG GCC CAG TGG AAC TCC GT -3'
The underlined regions of the oligonucleotides represent the
methyltransferase recognition sites. Oligos 1 and 3 are
complementary 37-mers used for the specific DNA binding assay.
Oligos 5 and 6 are complementary 29-mers used to detect non-
specific binding. Oligos 2 and 4 are complementary 37-mers that
in conjunction with oligos 1 and 3 can form either hemi-
methylated or fully methylated duplexes. To form duplexes,
appropriate complementary oligonucleotides were annealed by
heating at 80°C and gradually cooled to room temperature.
Purification of oligonucleotides, labeling procedures and DNA-
binding assays were performed as described previously (19)
except that the DNA was labeled with [a-32P]dATP and
[a-32P]dCTP with a specific activity of 6000Ci/mmol.
Complex dissociation
Complexes between the purified methyltransferase and the
labeled, unmethylated duplex 37-mer (oligos # 1 and 3) were
formed as described previously (19). Briefly, the binding reaction
was carried out in 10 y\ binding buffer (50 mM Tris.HCl (pH
8.0), 10 mM Na2EDTA, 7 mM /3-mercaptoethanol, 100 /tM
SAH, and 13% glycerol. Unless indicated otherwise, 27 nM
methyltransferase and 81 nM radiolabelled DNA probe were
used. The reaction was incubated at 22°C for 30 mins. and the
unlabeled DNA (8.1 yM) was added at timed intervals as
indicated in Figure 4. The complexes were analyzed by
electrophoresis on native 10% polyacrylamide gels run in TBE
(89 mM Tris.borate (pH 8.0), 2mM Na2EDTA). The gel was
prerun at 100 volts for 60 mins. Following electrophoresis the
gel was dried and analyzed using a Phosphor-Imager (Molecular
Dynamics) and also by autoradiography.
RESULTS
Mutant methyltransferases and cell growth
Site directed mutagenesis was used to replace the conserved
cysteine at position 81 in the P-C motif of M.Hhal. The mutant
methyltransferases were expressed from the early T7 promoter
under the control of the lac operator (15). Expression of the
methyltransferases was induced by IPTG, and their effects on
cell growth were monitored. Cells were removed at various times
after induction and replated, without induction, to test die number
of viable cells remaining. The results are shown in Figure 1. Cells
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Figure 1. Effects of mutant methyltransferases on cell growth. Cells harboring
expression plasmids for wild-type or mutant methyltransferases were induced by
IPTG and then plated out at different times. Colonies were counted after 12 hrs
and the colony forming units per ml was determined. Vector is the control plasmid
without insert. Cys indicates wild-type M.Hhal containing Cys at position 81.
His and Gly indicate mutants of M.Hhal containing His or Gly at position 81.
Cys(s) and Gly(s) indicate the coexpression of wild-type M.Hhal or the Gly-81
mutant in the presence of M.&rf.
Methyltransferase
Cys-81 (wt)
Arg-81
Gly-81
His-81
Ser-81
none
3H (cpm)
92,125
378
426
491
463
410
Standard Deviation
+ / - 814
+ / - 61
+ / - 82
+ / - 75
+ / - 83
+ / - 65
Cys-81 is the wild-type M.Hhal. The proteins were purified using the procedure
described previously (16) and assayed for methyltransferase activity using
bacteriophage lambda DNA, digested with HintHR, as substrate. Memylation was
monitored by the transfer of the radiolabeled methyl group from pH]-SAM.
Results were averaged from three experiments.
B
2* v< (7)
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Free
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Figure 3. Gly mutant protein binding properties. Gel mobility shift assays were
carried out as described in Materials and Methods using 27 nM methyltransferase
and 81 nm DNA. Panel A: Mutant (Gly-, His-, Arg-, Ser-81) or wild-type
(Cys-81) M.Hhal were purified by the standard procedure (16) and assayed for
binding to a DNA duplex containing the recognition sequence GCGC (oligos 1
and 3). Panel B: The Gly-81 mutant methyltransferase was purified from cells
co-expressing M.Sssl and assayed for binding as in Panel A. Wild-type M.Hhal
(Cys) is shown for comparison. Panel C: As Panel B, except that the
oligonudeotide contained the sequence CCGG in place of GCGC (oligos 5 and 6).
Figure 2. Mutant methyltransferase activity. Plasmid DNAs carrying wild-type
or mutant methyltransferases were isolated and compared with or without digestion
in vitro by Hhal restriction endonuclease (R.Hhal at top of figure). The digestion
products were analyzed by 1 % agarose gel electrophoresis in the presence of
0.5 /ig/ml ethidium bromide. The lane marked Vector contains plasmid DNA
with no insert. Cys inHirair* the plasmid DNA expressing wild-type M.Hhal.
Arg, Ser, His and Gly describe plastnid DNAs expressing the methyltransferase
genes that carry the indicated mutations at position 81.
expressing the Arg-81, His-81 or Ser-81 mutants grew as well
as cells expressing wild-type M.Hhal. The data (not shown) for
the Arg-81 and Ser-81 mutants paralleled that for His-81. Cells
expressing the Gly-81 mutant were much less viable and no
plasmid DNA could be isolated from cells grown from the
survivors at the final time point in Figure 1. This is similar to
the case of M.EcoRH where a Gly mutant in the P-C motif was
cytotoxic (13).
Mutant methyltransferase activities
Two tests were used to assay the activity of the mutant
methyltransferases. First, plasmid DNAs from cells expressing
the wild-type or mutant methyltransferase were isolated and their
sensitivity to digestion by R.Hhal was determined in vitro. Active
methyltransferases should methylate the plasmid in vivo, thereby
protecting it from digestion in vitro by R.Hhal. Figure 2 shows
that plasmid DNA from cells expressing the wild-type
methyltransferase gene was completely protected from R.Hhal
digestion, whereas none of the plasmid DNAs expressing mutant
methyltransferases were protected.
Second, the methylation activity of the wild-type and mutant
methyltransferases was determined by measuring their ability to
transfer [3H]-labeled methyl groups from SAM to bacteriophage
lambda DNA. Except for the Gly-81 mutant, the methyltrans-
ferases were purified close to homogeneity using a protocol
similar to that developed for wild-type M.Hhal (16). No Gly-81
mutant was detected after the protamine sulfate precipitation step
in the normal protocol. A modified procedure was used in which
this step was replaced by a brief incubation with DNAse I. The
final preparation was close to homogeneity as judged by SDS-PA-
GE. In contrast to the highly active wild-type enzyme, all of the
mutants had activities close to background levels indicating that
they were inactive as methyltransferases (Table 1).
Protein purification and DNA binding activity
The purified methyltransferases were tested for their ability to
bind, in a gel shift assay, to a synthetic duplex 37-mer
oligonudeotide containing the recognition sequence GCGC
(Oligos 1 and 3). Although the Ser-81, His-81 and Arg-81
mutants were enzymatically inactive, they can bind to the duplex
37-mer as efficiently as does wild-type M.Hhal containing Cys-81
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Figure 4. Dissociation of the DNA-methyltransferase complexes. A. The Gly-81
mutant protein, Gly(s), was purified from E.coli coexpressing M.&rl. 40 nM
wild-type M.Hhal (Cys) or 3 nM Gly-81 methyltransferase were incubated with
50 nM radtolabeled duplex probe containing the GCGC target sequence (oligos
1 and 3). The protein-DNA complex was then incubated with a 100 fold excess
of unlabeled probe for different times. The amount of oligonucleotide bound to
protein at different times was quantitated using a Phosphor-lmager (Molecular
Dynamics). The data for die Arg-81, His-81 and Ser-81 mutants are not shown,
but were used to plot the results seen in panel B. The protein and oligonucleotide
concentrations were such that binding was within the linear range. B. The time
courses for dissociation of protein-DNA complexes between the wild-type M .Hhal
(Cys) or the various mutants at position 81 (Arg, Gly, His, Ser) and a duplex
oligonucleotide containing the recognition sequence (oligos 1 and 3) were calculated
and normalized with respect to the total bound complex before the addition of
competitor oligonucleotide.
(Figure 3). Unexpectedly, the Gly-81 mutant, purified by a
modified version of the protocol used for the wild-type enzyme
(16), showed no signs of DNA binding. However, the overall
yield of this mutant methyltransferase was quite low. We
considered the possibility that the Gly-81 mutant protein might
in fact be a very strong DNA-binding protein and that we had
actually purified only a small portion of it as a complex with
DNA fragments. This was investigated by treating the purified
wild-type or Gly-81 mutant proteins with T4-polynucleotide
kinase and Y-P^-ATP. Following the labelling, the mixture was
extracted with phenol and the putative DNA products were
analyzed by gel electrophoresis. A signal corresponding to
labelled DNA was observed with the purified Gly-81 mutant,
but not from a control preparation of purified wild-type M.Hhal
(not shown).
To purify the Gly-81 methyltransferase free of DNA, we
coexpressed the Gly-81 mutant in the presence of a plasmid
encoding another methyltransferase, M.Sssl. M.&sl forms
5-methylcytosine within the sequence CG (20) and would thus
convert the M.Hhal recognition sequence, GCGC, into
Gm5CGC. We anticipated that this prior methylation would block
or weaken DNA binding by the wild-type M.Hhal and also of
the Gly-81 mutant. This expectation was completely fulfilled.
Purification of the Gly-81 mutant was greatly facilitated from
a strain coexpressing M.&sl (designated Gly(S) in Figures 1 and
3). In a gel shift assay, the Gly-81 mutant protein showed complex
formation that was similar to that of wild-type M.Hhal. The
purified Gly-81 mutant protein was able to bind the specific
synthetic 37-mer (Oligos 1 and 3) containing the GCGC sequence,
but not a control 29-mer (oligos 5 and 6) containing a CCGG
sequence (Fig. 3, panels B and C). These results demonstrate
that the binding is specifically contributed by the Gly-81 mutant
methyltransferase, and is not a result of M.&sl contamination.
Kinetics of dissociation
Dissociation rates were determined for the complexes between
the mutant methyltransferases and a duplex oligonucleotide
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Figure 5. Equilibrium binding of various methyltransferases to DNA. A. Wild-type M.Hhal (Cys) or mutants at position 81 (His, Gly), at the concentrations indicated,
were incubated for 30 min at 22°C in a binding reaction that also contained SAH and the labelled 37-mer duplex DNA (oligos 1 and 3). Separate controls (not
shown) established that in each case the binding reached equilibrium under the conditions used. Samples were analyzed by electrophoresis on a 10% native potyacrylamide
gel. The gel was dried and the bands quantitated using a Phosphor-lmager. B. The Kj values for wild-type and mutant M.Hhal were determined by Scatchard analyses,
r = bound DNA probe/total input protein. [S]f = free DNA probe.
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containing the GCGC recognition sequence. Complexes were
formed between labelled DNA and the methyltransferase and then
an excess of unlabelled oligonucleotide was added. Under the
conditions used only specific complexes were seen. The amount
of complex remaining in the reaction was measured as a function
of time using a gel mobility shift assay (Figure 4A) and the results
were quantitated. The amount of oligonucleotide bound by protein
at different times was calculated from Phosphor-Imager analysis.
The t1/2, the time required for half of the complex to dissociate,
and K^, were calculated from the data in Figure 4. The derived
values for t1/2 and k<,ff are shown in Table 2. The tXn for the
Gly-81 mutant was increased about 50-fold over wild-type.
The dissociation constants (Kj) for the specific interaction
between the wild-type and mutant methyltransferases with an
oligonucleotide duplex containing the recognition sequence was
calculated from a Scatchard analysis of the gel mobility-shift data
(Figure 5). For this analysis we used a fixed protein concentration
and varied the input DNA concentration as indicated in Figure 5.
Each complex was assumed to contain one molecule of protein
bound to one molecule of DNA (19). The bound protein
concentrations were calculated as the difference between the total
input oligonucleotide concentration minus the free oligonucleotide
concentration. The Kj values obtained from this analysis, based
on Kd=[S][P]/[SP], are shown in Table 2. It can be seen that
the Gly-81 mutant binds DNA 3-fold more tightly than the wild-
type methyltransferase or the Ser-81 mutant. In contrast, the
Arg-81 and His-81 mutants bound 10-fold and 20-fold more
weakly than wild-type respectively.
DISCUSSION
The DNA methyltransferases that form 5-methylcytosine share
a common architecture and contain a motif with absolutely
conserved proline and cysteine residues (termed the P-C motif)
that forms part of their catalytic center. Mutations at this
conserved cysteine residue in M.£coRII result in the abolition
of catalysis when Gly, Ser, Val or Tip are present (13) and a
Cys to Ser mutation abolishes activity in the SPR
methyltransferase (12). A mutant containing Gly at this position
in M.£coRII is cytotoxic to E.coli. We were interested to know
if this is a general phenomenon and, if so, to determine the cause
of cytotoxicity since it might be informative about
methyltransferase structure and function. We chose to study
M.Hhal because this methyltransferase has recently been
crystallized in our laboratory and its structure determination is
in progress (16). Four mutants were generated by site-directed
mutagenesis. The Cys-81 of the P-C motif was changed into either
a Gly, Arg, Ser or His residue.
First, we determined the effects of the mutants on cell growth.
Cells expressing the Gly-81 mutant methyltransferase were much
less viable than cells expressing the Arg-81, Ser-81 or His-81
mutants. This parallels results obtained in the M.EcoRII system
(13). We suspected that expression of the Gly-81 mutant
methyltransferase was cytotoxic because of enhanced DNA
binding to the target GCGC sequence, which might be expected
to interfere with DNA replication and/or transcription. Two lines
of evidence support this idea. First, the Gly-81 mutant protein,
purified from the usual E.coli host, was found to contain bound
DNA that rendered it unable to bind in vitro to exogenously-added
oligonucleotides containing the GCGC sequence. Second, in vitro
binding studies of the Gly-81 mutant purified free of DNA
showed that it was a stronger DNA binding protein than the
wild-type.
To purify the Gly-81 mutant free of DNA we co-expressed
it in the presence of M.&sl, which methylates all CG sequences.
We anticipated that M.Hhal and its Gly-81 mutant would
probably bind very poorly to pre-methylated DNA, the product
of the normal methylation reaction and so might be available in
free form from this strain. Cells harboring both the M.&sl and
Gly-81 mutant methyltransferase grew more slowly than cells
expressing a single methyltransferase. This phenomenon also
occurred in cells coexpressing the wild-type M.Hhal and M.&sl
methyltransferases (Fig 1) and in cells expressing M.Siyl alone
(data not shown). This slower growth is probably due to
methylation by M.&sl of sites required for normal cell growth
because M.&sl was constitutively expressed in the cells. It proved
easy to purify the Gly-81 mutant protein, free of DNA, from
this strain and the purified protein was then proficient for DNA
binding (Figure 3). The observed binding was not due to M.SwI
contamination since no shifted complex was seen when an
oligonucleotide containing the sequence CCGG was used.
The K^ values (Table 2) indicate that the Gly-81 mutant has
a higher affinity for its target DNA than the wild-type
methyltransferase. The koff values further (Table 2) substantiate
this result. Because of the inherent difficulties in measuring
accurate K^ values using gel shift assays the absolute values
reported here should be treated with caution. There appears to
be an inverse correlation between the sidechain length of the
amino acid at position 81 and the stability of the DNA-protein
complex. It is likely that a bulky side chain creates steric problems
during the initial interaction between the methyltransferase and
its DNA substrate leading to low affinity for the Arg-81 and
His-81 mutants. This will be reflected in increased koff values
because of the instability of the interaction between the protein
and its target sequence. In contrast, the Gly-81 mutant has no
side chain and has the apparent effect of stabilizing the complex
between the mutant methyltransferase and its DNA target. The
results reported here are fully consistent with the role of the P-C
motif as the active site of DNA m5C-methyltransferases (9,10).
We have already reported the successful crystallization of
M.Hhal in complex with its cofactor S-adenosylmethionine (16).
Unfortunately, it is not possible to obtain crystals of the wild-
type M.Hhal in complex with both SAM and DNA, because such
a complex would be competent for catalysis. However, it may
be possible to obtain crystals between the Gly-81 mutant and
DNA in the presence of SAM. Such a complex might be expected
to resemble the wild-type complex, but would be catalytically
inactive. This would give further insight into the reaction
mechanism and would complement structural studies of both the
Table 2. Kinetic constants for the methyltransferases
Methyltransferase lm (min) k^xlO"3 (min"1) KjXlO"9 M
Cys-81 (wt)
Arg-81
Gly-81
His-81
Ser-81
11
1.5
568
0.63
69
65
481
1.2
1000
10
1.25
11
0.45
20
1.69
Cys-81 is the wild-type M.Hhal. tm and k^ (values calculated as ln2/t1/2) were
from the data of Figure 4B. The Kj was calculated by Scatchard analysis from
the data of Figure 5.
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M.Hhal-SAiM complex, which is almost complete, and that of
a complex between M.Hhal, S-adenosylhomocysteine and DNA,
which is currently in progress (S. Klimasauskas, R.J. Roberts
and X. Cheng, submitted for publication).
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